Literature DB >> 11290886

Lymphoscintigraphic sentinel node imaging and gamma probe detection in breast cancer with Tc-99m nanocolloidal albumin: results of an optimized protocol.

T Rink1, T Heuser, H Fitz, H J Schroth, E Weller, H H Zippel.   

Abstract

PURPOSE: The purpose of this study was to aid in the standardization of lymphoscintigraphy for detecting the sentinel node (SN) in breast cancer using Tc-99m-labeled nanocolloidal albumin.
MATERIALS AND METHODS: One hundred twenty-three women with proved breast cancer were enrolled. Four injections of 10 to 15 MBq (0.27 to 0.41 mCi) Tc-99m nanocolloid in 0.1 ml physiologic saline were administered intra- and subdermally at the margin of the skin overlying the tumor. Planar scintigraphic images in the lateral and anterior projections were obtained 2.5 to 18 hours after tracer administration. With a gamma probe used as a guide, all radioactive lymph nodes in the axilla were resected. Complete dissection then followed.
RESULTS: In 116 of the 123 (94%) women, axillary nodal tracer uptake was revealed. Six of the 7 women in whom detection failure occurred had histologically proved tumor infiltration of the lymphatics and axillary involvement. In 36 (31%) of the patients with visualized lymph nodes, the SN was metastatic. The remaining 80 patients with negative SN included three cases with axillary involvement. The sensitivity of the SN with respect to the histologic status of the entire axilla thus was 92.3%, and the negative predictive value was 96.3%. The overall accuracy of the method was 97.4%. The number of hot nodes in women with and without axillary involvement was significantly different.
CONCLUSIONS: The described protocol represents an easily reproduced and reliable method for SN detection in breast cancer. Furthermore, the number of visualized axillary nodes reflects the histologic status of the axilla.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290886     DOI: 10.1097/00003072-200104000-00002

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  9 in total

Review 1.  Pharmaceutical strategies utilizing recombinant human serum albumin.

Authors:  Victor Tuan Giam Chuang; Ulrich Kragh-Hansen; Masaki Otagiri
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

2.  Postlumpectomy focal brachytherapy for simultaneous treatment of surgical cavity and draining lymph nodes.

Authors:  Brian A Hrycushko; Shihong Li; Chengyu Shi; Beth Goins; Yaxi Liu; William T Phillips; Pamela M Otto; Ande Bao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-09-23       Impact factor: 7.038

3.  Application of albumin-based nanoparticles in the management of cancer.

Authors:  Xinzhe Yu; Chen Jin
Journal:  J Mater Sci Mater Med       Date:  2015-11-26       Impact factor: 3.896

4.  A prototype small CdTe gamma camera for radioguided surgery and other imaging applications.

Authors:  Makoto Tsuchimochi; Harumi Sakahara; Kazuhide Hayama; Minoru Funaki; Ryoichi Ohno; Takashi Shirahata; Terje Orskaug; Gunnar Maehlum; Koki Yoshioka; Einar Nygard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-23       Impact factor: 9.236

5.  The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis.

Authors:  Sarah Pesek; Taka Ashikaga; Lars Erik Krag; David Krag
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

6.  Evaluation of Sentinel Lymph Node Biopsy and Axillary Lymph Node Dissection for Breast Cancer Treatment Concepts - a Retrospective Study of 1,214 Breast Cancer Patients.

Authors:  Roland G Stein; Roland Fricker; Thomas Rink; Hartmut Fitz; Sebastian Blasius; Joachim Diessner; Sebastian F M Häusler; Tanja N Stüber; Victoria Andreas; Achim Wöckel; Thomas Müller
Journal:  Breast Care (Basel)       Date:  2017-10-20       Impact factor: 2.860

7.  Hybrid Modality Fusion of Planar Scintigrams and CT Topograms to Localize Sentinel Lymph Nodes in Breast Lymphoscintigraphy: Technical Description and Phantom Studies.

Authors:  Renée L Dickinson; William D Erwin; Donna M Stevens; Luc M Bidaut; Martha V Mar; Homer A Macapinlac; Richard E Wendt
Journal:  Int J Mol Imaging       Date:  2010-12-14

Review 8.  Albumin-based drug delivery: harnessing nature to cure disease.

Authors:  Maja Thim Larsen; Matthias Kuhlmann; Michael Lykke Hvam; Kenneth A Howard
Journal:  Mol Cell Ther       Date:  2016-02-27

9.  Dual-modality imaging with 99mTc and fluorescent indocyanine green using surface-modified silica nanoparticles for biopsy of the sentinel lymph node: an animal study.

Authors:  Makoto Tsuchimochi; Kazuhide Hayama; Michio Toyama; Ichiro Sasagawa; Norio Tsubokawa
Journal:  EJNMMI Res       Date:  2013-04-25       Impact factor: 3.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.